Companies / Bioregen
Bioregen
Changzhou, China
The company is a high-tech enterprise mainly engaged in the research, development, production and sales of biological medical materials and other products.
Bioregen, based in Changzhou, China, has 2 investors on file, among them Eight Roads and F-Prime Capital. Its site was last checked 13 Nov 2026: site answers.
Investors
2 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital |
More from Eight Roads
28 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (28%), E-commerce & Marketplaces (15%), Fintech (15%).
More from F-Prime Capital
273 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (42%), Fintech (20%), AI & Machine Learning (10%).
See F-Prime Capital's full profile · Who invests alongside it
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Bioregen and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Eight Roads adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/bioregenmed.com/investors
# also
GET /v1/companies/bioregenmed.com
GET /v1/companies/bioregenmed.com/news